3 studies found for:    12860964 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Hydralazine/Magnesium;   Drug: Placebo;   Drug: Carboplatin;   Drug: Paclitaxel
2 Recruiting Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Interventions: Drug: Paclitaxel(intravenous) + Carboplatin(intravenous);   Drug: Paclitaxel(intravenous) + Carboplatin(intraperitoneal)
3 Completed
Has Results
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab

Indicates status has not been verified in more than two years